Investigating how certain toxins trigger autoimmune responses in the central nervous system.
Official title: Immune Privilege, CNS Autoimmunity, and Clostridium perfringens Epsilon Toxin
Funded at Weill Medical Coll of Cornell Univ · NIH-11088204 · Data updated 2026-11-12
This study is looking into why some people get Multiple Sclerosis (MS) while others don’t, even if they have similar genes, by exploring how certain toxins might affect the immune system and the brain, with the hope of finding new ways to diagnose and treat MS.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | June 1, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $662,275 |
| NIH project number | 5R01AI174064-03 |
| Project ID | NIH-11088204 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with a genetic predisposition to Multiple Sclerosis or those experiencing early symptoms of the disease.
✕Less likely to help
Patients who do not have a genetic risk for Multiple Sclerosis or are not experiencing any autoimmune symptoms may not benefit from this research.
What this research studies
This research aims to understand why some individuals develop Multiple Sclerosis (MS) while others with similar genetic predispositions do not. It focuses on the role of environmental triggers, specifically the toxins from Clostridium perfringens and Bordetella pertussis, in breaking down the immune barriers of the central nervous system. By studying how these toxins affect immune responses and the behavior of specific immune cells, the research seeks to identify new diagnostic tools and potential therapeutic targets for MS. The approach includes using animal models to observe the effects of these toxins on the immune system and the central nervous system.
Why it matters
Potential benefit: If successful, this research could lead to new diagnostic methods and treatments for Multiple Sclerosis.
How similar studies have gone: Previous research has shown promise in understanding autoimmune responses through similar mechanisms, but this specific approach is relatively novel.
Where this research is happening
-
Weill Medical Coll of Cornell Univ
New York, United States Active
Researchers
- Principal investigator: Vartanian, Timothy — Weill Medical Coll of Cornell Univ
- Study coordinator: Vartanian, Timothy
Related research
Other NIH-funded projects on the same topics.
-
Destruction of noncoding RNAs in cancer
This grant funds research to understand how noncoding RNAs are broken down, which could reveal new ways to influence cancer development and progression.
-
Coaching and Navigation by Community Health Workers via Telehealth for High-Risk Hypertension
A program using telehealth and community health workers to help adults with severe hypertension connect to primary care and follow practical, heart-healthy lifestyle tips.
-
Corticospinal neurons and recovery of precise forelimb movement after spinal cord injury
This project studies how spine injuries change brain circuits and whether targeted rehabilitation helps restore precise forelimb movement.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
ROMA:Women — comparing single vs multiple arterial grafts in women undergoing CABG
A women-focused clinical trial tests whether using more arterial grafts during heart bypass surgery improves outcomes and quality of life for women.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.